1xui: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
Line 1: Line 1:
[[Image:1xui.gif|left|200px]]
{{Seed}}
[[Image:1xui.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1xui|  PDB=1xui  |  SCENE=  }}  
{{STRUCTURE_1xui|  PDB=1xui  |  SCENE=  }}  


'''TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2'''
===TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2===




==Overview==
<!--  
Many serine proteases are targets for therapeutic intervention because they often play key roles in disease. Small molecule inhibitors of serine proteases with high affinity are especially interesting as they could be used as scaffolds from which to develop drugs selective for protease targets. One such inhibitor is bis(5-amidino-2-benzimidazolyl)methane (BABIM), standing out as the best inhibitor of trypsin (by a factor of over 100) in a series of over 60 relatively closely related analogues. By probing the structural basis of inhibition, we discovered, using crystallographic methods, a new mode of high-affinity binding in which a Zn2+ ion is tetrahedrally coordinated between two chelating nitrogens of BABIM and two active site residues, His57 and Ser 195. Zn2+, at subphysiological levels, enhances inhibition by over 10(3)-fold. The distinct Zn2+ coordination geometry implies a strong dependence of affinity on substituents. This unique structural paradigm has enabled development of potent, highly selective, Zn2+-dependent inhibitors of several therapeutically important serine proteases, using a physiologically ubiquitous metal ion.
The line below this paragraph, {{ABSTRACT_PUBMED_9468142}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 9468142 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_9468142}}


==About this Structure==
==About this Structure==
Line 35: Line 39:
[[Category: Designed small molecule ligand with micromolar affinity]]
[[Category: Designed small molecule ligand with micromolar affinity]]
[[Category: Trypsin-small molecule ligand]]
[[Category: Trypsin-small molecule ligand]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 15:31:28 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 03:52:40 2008''

Revision as of 00:52, 29 July 2008

File:1xui.png

Template:STRUCTURE 1xui

TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2

Template:ABSTRACT PUBMED 9468142

About this Structure

1XUI is a Single protein structure of sequence from Bos taurus. Full crystallographic information is available from OCA.

Reference

Design of potent selective zinc-mediated serine protease inhibitors., Katz BA, Clark JM, Finer-Moore JS, Jenkins TE, Johnson CR, Ross MJ, Luong C, Moore WR, Stroud RM, Nature. 1998 Feb 5;391(6667):608-12. PMID:9468142

Page seeded by OCA on Tue Jul 29 03:52:40 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=1xui&oldid=725873"